Wait, an earlier post said that "tutes own 89%" If tutes own 89% and shorts own almost 18%, then how are there any shares left over for anyone to "invest" in?
SHORT INTEREST 1,785,000 shares short,......17.56% of float (WOW). EPS -$2.68 per share (UGLY), held by institutions 7.89% (they HATE this trash). Why would anyone in their right mind invest in this scam stock. Heck, even ARNA has a better chance of success with their Belviq (LOL).
LJPC gets an upgrade from some clown outfit, and promptly tanks! NRZ gets a downgrade (the only one out of 10 or more real analysts) and they catch on fire! Interesting dymanic, a real company versus shady biotech!
No, here is a real company: GDPMQ. Well okay, it's a #$%$ company, but it would probably be considered pretty good on this (or ARNA's) board.
Watch what you say...at the top of the news section on Yahoo's ARNA page is an article that babs wrote for Motley Fool. Something about how owning #$%$ biotechs is like drawing with a crayon.
The price was higher when that target was given so yes, a $10 premium over the current price is a good thing
Sentiment: Strong Buy
5/20/16 quarterly report: We have incurred significant losses and negative cash flows from operations since our spinoff from Integrated BioPharma, Inc. in August 2008. As of March 31, 2016, our accumulated deficit was approximately $54.9 million, and we used approximately $5.2 million of cash for operating activities for the nine months ended March 31, 2016. As of March 31, 2016, cash on hand was approximately $21.9 million. In April 2016, the Company received approximately $4.0 million from the sale of 6,500,000 shares of common stock to Eastern. The cash on hand and the proceeds from Eastern share purchase in April 2016 is expected to support the Company's activities at least through March 31, 2017.
We have historically financed our activities through the sale of common stock and warrants. We plan to fund our future business operations using cash on hand, through proceeds from the sale of additional equity and other securities and through proceeds realized in connection with license and collaboration arrangements and operation of the Company's new subsidiary, iBio CMO.
Looks like a real winner here. Selling shares in a penny stock company to fund expenses and overhead, no earnings, but management makes out like a bandit. Hope shareholders in IBIO know they're no doing anything but paying salaries and bonuses for skeevy management (wonder if babstheidiot's the CFO there)?
Don't they call that MASSIVE DILUTION OF A PENNY STOCK SCAM????
"price target of $25"
Lets see...this was $45 when you were pumping it and the current price target is $25...and you think that's a good thing?
Sorry, but that's just not possible. There's a guy named babsnoseknot who says LJPC NEVER goes down. Oh and he brags about it NOT paying a dividend too. BWAAAAAAAAAA.
There's no way I'd pay LESS than $40.00 for LJPC. Last Fall there was a guy who kept "invading" the NRZ board who swore that since LJPC was in the $40s, that meant it could only go up. I guess (by his logic) that means if it's less than $40.00, it can only go down!